To the full analysis
Mycronic stock: growth
MYCR.STMycronic reported $795.95M in revenue for fiscal 2025, up 12.5% on the prior year, up 15.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10.4%
per year from 2006 to 2025, per share 2.6%
Earnings (Annual rate)
16%
per year from 2006 to 2025, per share 7.8%
Free cash flow (Annual rate)
13.3%
per year from 2006 to 2025, per share 5.3%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 15.4% | 15.9% | 10.4% |
| Revenue per share | 0.5% | 8.2% | 2.6% |
| Earnings | 17.6% | 13.4% | 16.0% |
| Earnings per share | 2.4% | 5.9% | 7.8% |
| Free cash flow | 5.8% | 7.5% | 13.3% |
| Free cash flow per share | −7.8% | 0.4% | 5.3% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $120.74M | $9.32M | $12.28M |
| 2007 | $52.44M | −$20.81M | −$12.21M |
| 2008 | $57.02M | $3.07M | $2.27M |
| 2009 | $83.11M | −$14.45M | $7.44M |
| 2010 | $129.13M | $3.69M | $8.16M |
| 2011 | $120.08M | −$8.91M | −$4.93M |
| 2012 | $135.76M | −$4.41M | $6.15M |
| 2013 | $99.97M | $1.38M | −$8.45M |
| 2014 | $147.9M | $26.7M | $40.01M |
| 2015 | $181.99M | $44.37M | $63.74M |
| 2016 | $232.56M | $52.77M | $42.03M |
| 2017 | $300.93M | $62.8M | $93.64M |
| 2018 | $379.08M | $79.17M | $63.53M |
| 2019 | $431.87M | $85.73M | $39.41M |
| 2020 | $389.25M | $69.59M | $99.37M |
| 2021 | $464.76M | $83.02M | $91.05M |
| 2022 | $513.29M | $74.3M | $71.39M |
| 2023 | $572.15M | $100.07M | $141.78M |
| 2024 | $707.62M | $168.76M | $164.04M |
| 2025 | $795.95M | $156.42M | $131.96M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.